Prattes, J; King, T; Azie, N; Angulo, D.
Oral Ibrexafungerp outcomes by fungal disease in patients from an interim analysis of a Phase 3 Open-label Study (FURI)
MED MYCOL. 2022; 60(SUPP 1): 58-59.
Doi: 10.1093/mmy/myac072.P056
[Poster]
Web of Science
FullText
FullText_MUG